Stay informed with us

Gain timely investment insights on:

Market Views & Allocation
Investment Ideas & Opportunities

By subscribing, you agree to receive research insights and marketing communications from us. You may unsubscribe at any time. See our Privacy Policy for details.

IR Hong Kong / China | Institutional Research | UOB Kay Hian | UOB Kay Hian

Institutional Research

Hong Kong / China

Company Coverage

View all

Fuyao Glass (3606 HK): 2Q26: Core Earnings Up 10% yoy On Margin Gain, Missing Our Estimates But Meeting Consensus; Cut Target Price To HK$84

Company Coverage

20 Aug 2026

Fuyao Glass (3606 HK): 2Q26: Core Earnings Up 10% yoy On Margin Gain, Missing Our Estimates But Meeting Consensus; Cut Target Price To HK$84

Sino Biopharmaceutical (1177 HK): 1H26: Results In Line; Innovative Products Continue To Drive Growth

Company Coverage

20 Aug 2026

Sino Biopharmaceutical (1177 HK): 1H26: Results In Line; Innovative Products Continue To Drive Growth

Kuaishou Technology (1024 HK): 2Q26: Results Broadly In Line, But Outlook Weaker Than Expected

Company Coverage

20 Aug 2026

Kuaishou Technology (1024 HK): 2Q26: Results Broadly In Line, But Outlook Weaker Than Expected

Ping An Healthcare and Technology Company (1833 HK): 1H26: Bottom Line Beat On Margin Expansion; Non-core Business Run-off Weighs On 2026 Revenue

Company Coverage

20 Aug 2026

Ping An Healthcare and Technology Company (1833 HK): 1H26: Bottom Line Beat On Margin Expansion; Non-core Business Run-off Weighs On 2026 Revenue

China Resources Beer (291 HK): 1H26: Earnings Miss; Softer Expectations For Volume And ASP In 2026

Company Coverage

20 Aug 2026

China Resources Beer (291 HK): 1H26: Earnings Miss; Softer Expectations For Volume And ASP In 2026

Crystal International (2232 HK): 1H26: Solid Performance Despite Capacity Constraints; Accelerating Growth In 2H26

Company Coverage

20 Aug 2026

Crystal International (2232 HK): 1H26: Solid Performance Despite Capacity Constraints; Accelerating Growth In 2H26

Baidu Inc (9888 HK): 2Q26: Earnings Miss; AI Growth Accelerates, But Sustainability Remains To Be Proven

Company Coverage

19 Aug 2026

Baidu Inc (9888 HK): 2Q26: Earnings Miss; AI Growth Accelerates, But Sustainability Remains To Be Proven

Pony.ai (PONY US): 2Q26: Revenue Beats On A 691% Robotaxi Surge

Company Coverage

19 Aug 2026

Pony.ai (PONY US): 2Q26: Revenue Beats On A 691% Robotaxi Surge

Xiaomi Corp (1810 HK): 2Q26: Smartphone May See Better-Than-Expected Trough Levels, But Other Segments Continue To Deteriorate

Company Coverage

19 Aug 2026

Xiaomi Corp (1810 HK): 2Q26: Smartphone May See Better-Than-Expected Trough Levels, But Other Segments Continue To Deteriorate

CSPC Innovation Pharmaceutical Co (300765 CH): 1H26: Achieves Breakeven; Smooth BD And R&D Progress Bolster Long-Term Prospects

Company Coverage

19 Aug 2026

CSPC Innovation Pharmaceutical Co (300765 CH): 1H26: Achieves Breakeven; Smooth BD And R&D Progress Bolster Long-Term Prospects

Hesai Group (2525 HK): 2Q26: Miss On ASP And Other Incomes; 3Q26 Revenue To Accelerate; 2026 Shipment Target Kept With SGI Revenue Lifted

Company Coverage

19 Aug 2026

Hesai Group (2525 HK): 2Q26: Miss On ASP And Other Incomes; 3Q26 Revenue To Accelerate; 2026 Shipment Target Kept With SGI Revenue Lifted

Country Daily

View all

China Resources Beer / Crystal International / Fuyao Glass / Hong Kong Exchanges and Clearing / Kuaishou Technology / Ping An Healthcare and Technology / Sino Biopharmaceutical

Country Daily

20 Aug 2026

China Resources Beer / Crystal International / Fuyao Glass / Hong Kong Exchanges and Clearing / Kuaishou Technology / Ping An Healthcare and Technology / Sino Biopharmaceutical

China Healthcare: Innovation And Globalisation: The Twin Engines For Growth

Periodic/Sector reports

8 Sept 2026

China Healthcare: Innovation And Globalisation: The Twin Engines For Growth

China Property: Shanghai Shifts Housing Supply From New Build To Renewal; National Land Supply Keeps Shrinking

Periodic/Sector reports

8 Sept 2026

Stay informed with us

Hong Kong / China

Company Coverage

Fuyao Glass (3606 HK): 2Q26: Core Earnings Up 10% yoy On Margin Gain, Missing Our Estimates But Meeting Consensus; Cut Target Price To HK$84

Sino Biopharmaceutical (1177 HK): 1H26: Results In Line; Innovative Products Continue To Drive Growth

Kuaishou Technology (1024 HK): 2Q26: Results Broadly In Line, But Outlook Weaker Than Expected

Ping An Healthcare and Technology Company (1833 HK): 1H26: Bottom Line Beat On Margin Expansion; Non-core Business Run-off Weighs On 2026 Revenue

China Resources Beer (291 HK): 1H26: Earnings Miss; Softer Expectations For Volume And ASP In 2026

Crystal International (2232 HK): 1H26: Solid Performance Despite Capacity Constraints; Accelerating Growth In 2H26

Baidu Inc (9888 HK): 2Q26: Earnings Miss; AI Growth Accelerates, But Sustainability Remains To Be Proven

Pony.ai (PONY US): 2Q26: Revenue Beats On A 691% Robotaxi Surge

Xiaomi Corp (1810 HK): 2Q26: Smartphone May See Better-Than-Expected Trough Levels, But Other Segments Continue To Deteriorate

CSPC Innovation Pharmaceutical Co (300765 CH): 1H26: Achieves Breakeven; Smooth BD And R&D Progress Bolster Long-Term Prospects

Hesai Group (2525 HK): 2Q26: Miss On ASP And Other Incomes; 3Q26 Revenue To Accelerate; 2026 Shipment Target Kept With SGI Revenue Lifted

Country Daily

China Resources Beer / Crystal International / Fuyao Glass / Hong Kong Exchanges and Clearing / Kuaishou Technology / Ping An Healthcare and Technology / Sino Biopharmaceutical

Our latest research

China Healthcare: Innovation And Globalisation: The Twin Engines For Growth

China Property: Shanghai Shifts Housing Supply From New Build To Renewal; National Land Supply Keeps Shrinking

Greater China Strategy / China Healthcare / China Property